Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Antihormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Exogenous hormones |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
3-beta-androstanediol (substance) |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Peptide hormones and their metabolites and precursors |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Catecholamine and/or catecholamine derivative |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Prostaglandin |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Prepro-opiomelanocortin |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Melatonin |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Hormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Hormones and their metabolites and precursors A - G |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Hormones and their metabolites and precursors H - S |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Hormones and their metabolites and precursors T - Z |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Sex hormone (substance) |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Non-sex hormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Fetoplacental hormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Pituitary or adrenal hormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Antiestrogen |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Substance with androgen receptor antagonist mechanism of action |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Antigonadotropin |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Antimineralocorticoid |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing bicalutamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing selective estrogen receptor modulator (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing finasteride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing carbimazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Carbimazole 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Carbimazole 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Propylthiouracil 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Finasteride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Clomifene citrate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing cyclofenil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Metyrapone 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Gestrinone 2.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing precisely trilostane 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing precisely trilostane 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Raloxifene hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Raloxifene hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Mifepristone 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing lynestrenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
gestronol hexanoate 100mg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Cyproterone acetate 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Cyproterone acetate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing precisely tamoxifen 10 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing precisely tamoxifen 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Tamoxifen 10mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing precisely tamoxifen 40 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Flutamide 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Bicalutamide 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Bicalutamide 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing androgen receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
contraceptif oral combiné |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing cyproterone acetate and ethinyl estradiol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Phased cocs- ethinylestradiol+levonorgestrel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Sex hormone product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing estrogen receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
hormones, produits de substitution synthétiques et antagonistes |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Thiourea antithyroid agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Thiouracil antithyroid agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing gestonorone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Phased oral contraceptive |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Fertility agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing toremifene citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Cyproterone acetate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Mineralocorticoids and their antagonists |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Antigonadotrophins, antiestrogens, antiandrogens |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing nafoxidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Médicament progestatif |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing hormone (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing trilostane (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing synthetic hormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing clomifene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Cortisone derivative |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Glucocorticoids and synthetic analogs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing propylthiouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing iothiouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
médicament antithyroidien |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing metyrapone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Natural hormone preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Oral contraceptive preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing clomifene citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing methylthiouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing androgen receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing tamoxifen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing norgestomet (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing altrenogest (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Synthetic antihormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing synthetic antiandrogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing cyproterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing flutamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing synthetic antiestrogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing toremifene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Synthetic antigonadotropin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing gestrinone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing paroxypropione (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Product containing mifepristone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Endocrine drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Drugs for hypoglycemia |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Diabetic neuropathy treatment [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Corticosteroid replacement therapy |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Steroid disease suppression [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|
Corticosteroid disadvantages [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Some |
|